Skip to main content
Clinical Trials/CTRI/2019/02/017553
CTRI/2019/02/017553
Not yet recruiting
未知

Comparison of efficacy , safety & tolerability of intravenous ferric carboxymaltose with intravenous iron sucrose for treatment of iron deficiency anemia in pregnancy

Department of Obstetrics and Gynecology0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Obstetrics and Gynecology
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Obstetrics and Gynecology

Eligibility Criteria

Inclusion Criteria

  • Antenatal women with (20\-34 weeks ) gestation with diagnosed iron deficiency anemia of varying severity(Hb 6\-9\.9g/dl)
  • Singleton pregnancy

Exclusion Criteria

  • Hemodynamic instability or clinically perceived or anticipated need of blood transfusion
  • History of repeated blood transfusions
  • Haemoglobinopathies bleeding diathesis
  • Known history of asthma allergies hypersensitivity reactions eczema
  • History of hypersensitivity reaction to iron preparations
  • Advanced Systemic illnesses involving renal/hepatic /cardiovascular system
  • Conditions associated with iron overload viz thalessemia hemochromatosis

Outcomes

Primary Outcomes

Not specified

Similar Trials